Abstract
Disorders of the CYP21 gene, which is located within the major histocompatibility complex on the short arm of chromosome 6, are the leading causes of congenital adrenal hyperplasia (CAH). The coding gene and a highly homologous pseudogene are tandemly arranged with the two genes for the fourth component of complement (C4A and C4B). To analyse the prevalence rates of mutations of the CYP21 genes and the segregation of the CYP21 genes with their corresponding human leucocyte antigen (HLA)-haplotypes, 21 families with one or two children with the severe form of 21-hydroxylase deficiency were studied. Mutations of the CYP21 gene on their corresponding HLA-haplotype were detected by hybridisation of polymerase chain reaction (PCR)-amplified genomic DNA with sequence-specific oligonucleotides and solid phase direct sequencing. Our study has shown the following. (1) A single basepair mutation (A→G or C→G) within the second intron is the most frequent mutation leading to impaired 21-hydroxylase activity. This mutation is only detected in HLA-haplotypes associated with the salt-wasting form of CAH. (2) A large deletion of part or all of the CYP21 gene is associated with the HLA-haplotype A3, BW47, C6, DR7, DR53, DQ2 but is also observed in other HLA-haplotypes and can be detected by a simple rapid PCR restriction fragment length polymorphism method. (3) Two alleles of the coding CYP21 gene differing in a leucine codon within the first exon, (formerly described as a mutation associated with 21-hydroxylase deficiency) have been found with an equal distribution in patients with 21-hydroxylase deficiency, non-disease HLA-haplotypes and the local healthy controls.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amor M, Parker KL, Globermann H (1988) Mutation in the CYP21B gene (Ile-172-Asp). Proc Natl Acad Sci USA 85:1600–1604
Boehm BO, Rosak C, Boehm TLJ, et al (1986) Classical and lateonset forms of congenital adrenal hyperplasia caused by 21-OH deficiency reveal different alterations in the C4/21 -OH gene region. Mol Biol Med 3:437–448
Bouchard P, Kuttenn F, Mowszowicz I, Schaison G, Raux-Eurin MC, Mauvais-Jarvis P (1981) Congenital adrenal hyperplasia due to partial 21-hydroxylase deficiency. Acta Endocrinol (Copenh) 96:107–110
Carroll MC, Pasldottir A, Belt KT, Porter RR (1985) Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J 4:2547–2552
Donohoue PA, Dop CV, McLean RH, et al (1986) Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. J Clin Endocrinol Metab 62:995–1002
Dupont B, Oberfield SE, Smithwick ER, Lee TD, Levine LS (1977) Close linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet II:1309–1312
Fleischnick E, Awdeh ZL, Raum D, Granados J, Alosco SM, Crigler JF, Gerald PS, Giles CM, Yunis EJ, Alper CA (1983) Extended MHC haplotypes in 21-hydroxylase-deficiency congenital adrenal hyperplasia: shared genotypes in unrelated patients. Lancet II:152–156
Globerman H, Amor M, Parker KL, New MI, White PC (1988) Nonsense mutations causing steroid 21-hydroxylase deficiency. J Clin Invest 82:139–144
Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 83:2841–2845
Higashi Y, Tanae A, Inoue H, Fujii-Kuriyama Y (1988) Evidence for frequent gene conversion events in steroid 21-hydroxylase (P450c21) gene: implications for steroid 21-hydroxylase deficiency. Am J Hum Genet 42:17–25
Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y (1988b) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P450(C21)J deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA 85:7486–7490
Lee PA, Gareis FJ (1975) Evidence for partial 21-hydroxylase deficiency among heterozygote carriers of congenital adrenal hyperplasia. J Clin Endocrinol Metab 41:415–421
Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield S, Kohn B, Lerner A, Cacciare E, Mantero F, et al (1980) Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 51:1316
Nebert DW, Adesnik M, Coon MJ, et al (1987) The P450 gene superfamily: recommended nomenclature. DNA 6:1–11
New MI, Seaman MP (1970) Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. J Clin Endocrinol 30:361
New MI, White PC, Speiser PW, Crawford C, Dupont B (1989) In: Edwards CRW, Lincoln DW (eds) Endocrinology and metabolism. Churchill Livingstone, Edinburgh
Owerbach D, Crawford YM, Draznin MB (1990) Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification. Mol Endocrinol 4:125–131
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Sinnot P, Collier S, Costigan C, Dyer PA, Harris R, Strachan T (1990) Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 87:2107–2111
Uhlen M (1985) Magnetic separation of DNA. Nature 340:733–734
White PC, New MI, Dupont B (1985) Immunol Rev 87:123–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manfras, B.J., Swinyard, M., Rudert, W.A. et al. Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study. Hum Genet 92, 33–39 (1993). https://doi.org/10.1007/BF00216142
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00216142